Dr. Daniel Rosenbaum, MD, FRCPC, is an attending psychiatrist at UHN as well as the Inner City Health Associates (ICHA) in Toronto. He is also a clinical lecturer in the Department of Psychiatry at the University of Toronto. He works on an Assertive Community Treatment Team, serving people with severe and persistent mental illnesses (SPMI), as well as the Palliative Education and Care for the Homeless (PEACH) team through ICHA. Dr. Rosenbaum is interested in psychosocial oncology and palliative care, especially end-of-life issues for marginalized populations. He is a certified CALM therapist (Managing Cancer and Living Meaningfully) and has received training in ketamine-assisted psychotherapy and has completed the MAPS MDMA Therapy Training Program. He is also the co-founder of the Canadian Climate Psychiatry Alliance. Dr. Rosenbaum has published articles in peer-reviewed journals on psychedelic-assisted therapy in palliative and cancer care and on psychedelic microdosing. He is a co-founder and faculty member of the Nikean Psychedelic Psychotherapy Research Centre at UHN.